Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force
JT Henderson, EM Webber, GF Sawaya - Jama, 2018 - jamanetwork.com
Importance Ovarian cancer is relatively rare but the fifth-leading cause of cancer mortality
among United States women. Objective To systematically review evidence on benefits and …
among United States women. Objective To systematically review evidence on benefits and …
Applications of proteomics in ovarian cancer: dawn of a new era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - mdpi.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
[BOOK][B] Perez & Brady's principles and practice of radiation oncology
EC Halperin, LW Brady, CA Perez, DE Wazer - 2013 - books.google.com
Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic
coverage of topics ranging from basic science to sophisticated computer-based radiation …
coverage of topics ranging from basic science to sophisticated computer-based radiation …
Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial
SS Buys, E Partridge, A Black, CC Johnson… - Jama, 2011 - jamanetwork.com
Context Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective To evaluate the effect of screening …
ultrasound has an unknown effect on mortality. Objective To evaluate the effect of screening …
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the …
U Menon, A Gentry-Maharaj, R Hallett, A Ryan… - The lancet …, 2009 - thelancet.com
Background Ovarian cancer has a high case–fatality ratio, with most women not diagnosed
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata… - Molecular cancer, 2014 - Springer
Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study
Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …
investigation for possible ovarian cancer in symptomatic women presenting to primary care …
Screening for preeclampsia: US preventive services task force recommendation statement
Importance Preeclampsia affects approximately 4% of pregnancies in the United States. It is
the second leading cause of maternal mortality worldwide and may lead to serious maternal …
the second leading cause of maternal mortality worldwide and may lead to serious maternal …
[HTML][HTML] Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
RJ Kurman - Annals of Oncology, 2013 - Elsevier
A new paradigm for the pathogenesis of ovarian cancer has recently been proposed which
helps to explain persistent problems in describing the development and diverse morphology …
helps to explain persistent problems in describing the development and diverse morphology …
Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review
Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …
of less than 50%, making it one of the most lethal gynecological cancers for women in the …